跳至主要内容
临床试验/CTRI/2009/091/000628
CTRI/2009/091/000628尚未招募1 期

An open-label, randomized, 2-period, cross-over study to determine the relative bioavailability of AEB071 from a coated tablet versus a capsule in healthy subjects

ovartis Healthcare Private Limited0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Health volunteers of either gender between 18 to 45 years.
  • Women should be postmenopausal or surgically sterialized
  • Males should be using contraception

排除标准

  • History of any major illness, and abnormal lab assessment
  • Those who have intension to vaccine for 2 weeks or have had vaccine in the last 2 weeks

研究者

发起方
ovartis Healthcare Private Limited

相似试验